In these patients, the overall survival is greatly affected by attentive care and careful screening, which allow the prevention of recurrent infections and identifying tumors early. Usually, patients affected by the classical form of A-T can reach early adulthood. Milder forms and adult-onset variants have a significantly longer life expectancy. Median survival was noted to be 19-25 years with wide variability in two large cohorts.